Deakin University
Browse

INTERIM DATA FROM THE FIRST-IN-HUMAN PHASE 1/2A TRIAL OF ICM-203, AN INTRA-ARTICULAR, AAV GENE THERAPY FOR OSTEOARTHRITIS - SAFETY, TOLERABILITY, AND PRELIMINARY EVALUATION OF CLINICAL ACTIVITY IN LOW DOSE COHORT

journal contribution
posted on 2024-05-28, 05:32 authored by Alison E Heald, Lucien B Solomon, Richard PageRichard Page, Yoenhee Ahn, Young Na Yum, Jayhyuk Myung, Jamie E Collins, Ali Guermazi, Dae-Won Kim
INTERIM DATA FROM THE FIRST-IN-HUMAN PHASE 1/2A TRIAL OF ICM-203, AN INTRA-ARTICULAR, AAV GENE THERAPY FOR OSTEOARTHRITIS - SAFETY, TOLERABILITY, AND PRELIMINARY EVALUATION OF CLINICAL ACTIVITY IN LOW DOSE COHORT

History

Journal

Osteoarthritis and Cartilage

Volume

32

Pagination

S589-S589

ISSN

1063-4584

Language

eng

Publication classification

E3 Extract of paper

Publisher

Elsevier BV

Usage metrics

    Research Publications

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC